Bristol Myers Squibb strikes deal to sell NY site to South Korean conglomerate — but it's keeping quiet on the details
Bristol Myers Squibb’s manufacturing facility in East Syracuse, NY, is about to be swallowed up by one of the largest conglomerates in South Korea.
Lotte Corporation and BMS unveiled a fresh deal for the site on Friday while keeping most of the details — including the financing — under wraps. BMS even declined to disclose the site’s square footage in an email to Endpoints News.
Meanwhile, South Korea’s Yonhap News Agency reported that the deal cost Lotte $160 million. In return, the conglomerate gets the site, equipment and a workforce with “technical capabilities and expertise.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.